Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-16-110362
Filing Date
2016-04-07
Accepted
2016-04-07 16:10:41
Documents
1
Period of Report
2016-04-05

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3936
  Complete submission text file 0001104659-16-110362.txt   5382
Mailing Address DYAX CORP. 55 NETWORK DRIVE BURLINGTON MA 01803
Business Address
ADELMAN BURT A (Reporting) CIK: 0001226283 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37467 | Film No.: 161560213

Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Issuer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations